NEU-730

We are open as normal during COVID-19 pandemic. Order online, same day shipping out from North Carolina, USA

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 527490

CAS#: 1622300-88-2

Description: NEU-730 is a novel inhibitor of TbrPDEB1, showing modest inhibition of T. brucei proliferation.


Price and Availability

Size Price Shipping out time Quantity
Inquire bulk and customized quantity

Pricing updated 2020-10-31. Prices are subject to change without notice.

NEU-730 is not in stock, may be available through custom synthesis. For cost-effective reason, minimum 1 gram order is requested. The product will be characterized by NMR, HPLC and MS analysis. Purity (HPLC) is usually >98%. CoA, QC data, MSDS will be provided when product is successfully made. The estimated lead time is 2-3 months. Please send email to sales@medkoo.com to inquire quote.


Chemical Structure

img

Theoretical Analysis

MedKoo Cat#: 527490
Name: NEU-730
CAS#: 1622300-88-2
Chemical Formula: C25H29NO5
Exact Mass: 423.2046
Molecular Weight: 423.509
Elemental Analysis: C, 70.90; H, 6.90; N, 3.31; O, 18.89


Synonym: NEU-730; NEU730; NEU 730

IUPAC/Chemical Name: cis-4-Cyano-4-[4-methoxy-3-(4-phenoxybutoxy)phenyl]-cyclohexanecarboxylic acid

InChi Key: OGVVVHXXDFPPNX-KJDSRRNHSA-N

InChi Code: InChI=1S/C25H29NO5/c1-29-22-10-9-20(25(18-26)13-11-19(12-14-25)24(27)28)17-23(22)31-16-6-5-15-30-21-7-3-2-4-8-21/h2-4,7-10,17,19H,5-6,11-16H2,1H3,(H,27,28)/t19-,25+

SMILES Code: O=C([C@H]1CC[C@](C2=CC=C(OC)C(OCCCCOC3=CC=CC=C3)=C2)(C#N)CC1)O


Technical Data

Appearance:
Solid powder

Purity:
>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility:
Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:
2934.99.9001


References

1: Schwedhelm C, Nimptsch K, Bub A, Pischon T, Linseisen J. Association between alcohol consumption and serum paraoxonase and arylesterase activities: a cross-sectional study within the Bavarian population. Br J Nutr. 2016 Feb 28;115(4):730-6. doi: 10.1017/S0007114515004985. Epub 2016 Jan 15. PubMed PMID: 26769660.

2: Duncan MA, Wu J, Neu MC, Orr MF; Centers for Disease Control and Prevention (CDC). Persons injured during acute chemical incidents—Hazardous Substances Emergency Events Surveillance, nine states, 1999-2008. MMWR Suppl. 2015 Apr 10;64(2):18-24. PubMed PMID: 25856534.

3: Hummel AS, Hertel C, Holzapfel WH, Franz CM. Antibiotic resistances of starter and probiotic strains of lactic acid bacteria. Appl Environ Microbiol. 2007 Feb;73(3):730-9. Epub 2006 Nov 22. PubMed PMID: 17122388; PubMed Central PMCID: PMC1800751.

4: Acosta D, Affolder T, Ahn MH, Akimoto T, Albrow MG, Ambrose D, Amerio S, Amidei D, Anastassov A, Anikeev K, Annovi A, Antos J, Aoki M, Apollinari G, Arguin JF, Arisawa T, Artikov A, Asakawa T, Ashmanskas W, Attal A, Azfar F, Azzi-Bacchetta P, Bacchetta N, Bachacou H, Badgett W, Bailey S, Barbaro-Galtieri A, Barker G, Barnes VE, Barnett BA, Baroiant S, Barone M, Bauer G, Bedeschi F, Behari S, Belforte S, Bell WH, Bellettini G, Bellinger J, Benjamin D, Beretvas A, Bhatti A, Binkley M, Bisello D, Bishai M, Blair RE, Blocker C, Bloom K, Blumenfeld B, Bocci A, Bodek A, Bolla G, Bolshov A, Booth PS, Bortoletto D, Boudreau J, Bourov S, Bromberg C, Brubaker E, Budagov J, Budd HS, Burkett K, Busetto G, Bussey P, Byrum KL, Cabrera S, Calafiura P, Campanelli M, Campbell M, Canepa A, Carlsmith D, Carron S, Carosi R, Casarsa M, Castro A, Catastini P, Cauz D, Cerri A, Cerri C, Cerrito L, Chapman J, Chen C, Chen YC, Chertok M, Chiarelli G, Chlachidze G, Chlebana F, Cho K, Chokheli D, Chu ML, Chung JY, Chung WH, Chung YS, Ciobanu CI, Ciocci MA, Clark AG, Clark D, Coca MN, Connolly A, Convery ME, Conway J, Cordelli M, Cortiana G, Cranshaw J, Culbertson R, Currat C, Cyr D, Dagenhart D, DaRonco S, D'Auria S, de Barbaro P, De Cecco S, De Lentdecker G, Dell'Agnello S, Dell'Orso M, Demers S, Demortier L, Deninno M, De Pedis D, Derwent PF, Dionisi C, Dittmann JR, Doksus P, Dominguez A, Donati S, D'Onofrio M, Dorigo T, Drollinger V, Ebina K, Eddy N, Ely R, Erbacher R, Erdmann M, Errede D, Errede S, Eusebi R, Fang HC, Farrington S, Fedorko I, Feild RG, Feindt M, Fernandez JP, Ferretti C, Field RD, Fiori I, Flanagan G, Flaugher B, Flores-Castillo LR, Foland A, Forrester S, Foster GW, Franklin M, Frisch H, Fujii Y, Furic I, Gaijar A, Gallas A, Gallinaro M, Galyardt J, Garcia-Sciveres M, Garfinkel AF, Gay C, Gerberich H, Gerchtein E, Gerdes DW, Giagu S, Giannetti P, Gibson A, Gibson K, Ginsburg C, Giolo K, Giordani M, Giurgiu G, Glagolev V, Glenzinski D, Gold M, Goldschmidt N, Goldstein D, Goldstein J, Gomez G, Gomez-Ceballos G, Goncharov M, Gorelov I, Goshaw AT, Gotra Y, Goulianos K, Gresele A, Grosso-Pilcher C, Guenther M, Guimaraes da Costa J, Haber C, Hahn K, Hahn SR, Halkiadakis E, Hall C, Handler R, Happacher F, Hara K, Hare M, Harr RF, Harris RM, Hartmann F, Hatakeyama K, Hauser J, Hays C, Hayward H, Heider E, Heinemann B, Heinrich J, Hennecke M, Herndon M, Hill C, Hirschbuehl D, Hocker A, Hoffman KD, Holloway A, Hou S, Houlden MA, Huang Y, Huffman BT, Hughes RE, Huston J, Ikado K, Incandela J, Introzzi G, Iori M, Ishizawa Y, Issever C, Ivanov A, Iwata Y, Iyutin B, James E, Jang D, Jarrell J, Jeans D, Jensen H, Jones M, Jun SY, Junk T, Kamon T, Kang J, Karagoz Unel M, Karchin PE, Kartal S, Kato Y, Kemp Y, Kephart R, Kerzel U, Khotilovich V, Kilminster B, Kim BJ, Kim DH, Kim HS, Kim JE, Kim MJ, Kim MS, Kim SB, Kim SH, Kim TH, Kim YK, King BT, Kirby M, Kirsch L, Klimenko S, Knuteson B, Ko BR, Kobayashi H, Koehn P, Kondo K, Konigsberg J, Kordas K, Korn A, Korytov A, Kotelnikov K, Kotwal AV, Kovalev A, Kraus J, Kravchenko I, Kreymer A, Kroll J, Kruse M, Krutelyov V, Kuhlmann SE, Kuznetsova N, Laasanen AT, Lai S, Lami S, Lammel S, Lancaster J, Lancaster M, Lander R, Lannon K, Lath A, Latino G, Lauhakangas R, Lazzizzera I, Le Y, Lecci C, LeCompte T, Lee J, Lee J, Lee SW, Leonardo N, Leone S, Lewis JD, Li K, Lin CS, Lindgren M, Liss TM, Litvintsev DO, Liu T, Liu Y, Lockyer NS, Loginov A, Loken J, Loreti M, Loverre P, Lucchesi D, Lukens P, Lyons L, Lys J, MacQueen D, Madrak R, Maeshima K, Maksimovic P, Malferrari L, Manca G, Marginean R, Martin A, Martin M, Martin V, Martinez M, Maruyama T, Matsunaga H, Mattson M, Mazzanti P, McFarland KS, McGivern D, McIntyre PM, McNamara P, McNulty R, Menzemer S, Menzione A, Merkel P, Mesropian C, Messina A, Meyer A, Miao T, Miladinovic N, Miller L, Miller R, Miller JS, Miquel R, Miscetti S, Mishina M, Mitselmakher G, Miyamoto A, Miyazaki Y, Moggi N, Moore R, Morello M, Moulik T, Mukherjee A, Mulhearn M, Muller T, Mumford R, Munar A, Murat P, Nachtman J, Nahn S, Nakamura I, Nakano I, Napier A, Napora R, Necula V, Niell F, Nielsen J, Nelson C, Nelson T, Neu C, Neubauer MS, Newman-Holmes C, Nicollerat AS, Nigmanov T, Nodulman L, Oesterberg K, Ogawa T, Oh S, Oh YD, Ohsugi T, Oishi R, Okusawa T, Oldeman R, Orava R, Orejudos W, Pagliarone C, Palmonari F, Paoletti R, Papadimitriou V, Pashapour S, Patrick J, Pauletta G, Paulini M, Pauly T, Paus C, Pellett D, Penzo A, Phillips TJ, Piacentino G, Piedra J, Pitts KT, Pompos A, Pondrom L, Pope G, Poukhov O, Prakoshyn F, Pratt T, Pronko A, Proudfoot J, Ptohos F, Punzi G, Rademacker J, Rakitine A, Rappoccio S, Ratnikov F, Ray H, Reichold A, Rekovic V, Renton P, Rescigno M, Rimondi F, Rinnert K, Ristori L, Robertson WJ, Robson A, Rodrigo T, Rolli S, Rosenson L, Roser R, Rossin R, Rott C, Russ J, Ruiz A, Ryan D, Saarikko H, Safonov A, St Denis R, Sakumoto WK, Saltzberg D, Sanchez C, Sansoni A, Santi L, Sarkar S, Sato K, Savard P, Savoy-Navarro A, Schemitz P, Schlabach P, Schmidt EE, Schmidt MP, Schmitt M, Scodellaro L, Scribano A, Scuri F, Sedov A, Seidel S, Seiya Y, Semeria F, Sexton-Kennedy L, Sfiligoi I, Shapiro MD, Shears T, Shepard PF, Shimojima M, Shochet M, Shon Y, Sidoti A, Siket M, Sill A, Sinervo P, Sisakyan A, Skiba A, Slaughter AJ, Sliwa K, Smith JR, Snider FD, Snihur R, Somalwar SV, Spalding J, Spezziga M, Spiegel L, Spinella F, Spiropulu M, Squillacioti P, Stadie H, Stelzer B, Stelzer-Chilton O, Strologas J, Stuart D, Sukhanov A, Sumorok K, Sun H, Suzuki T, Taffard A, Tafirout R, Takach SF, Takano H, Takashima R, Takeuchi Y, Takikawa K, Tamburello P, Tanaka M, Tanaka R, Tanimoto N, Tapprogge S, Tecchio M, Teng PK, Terashi K, Tesarek RJ, Tether S, Thom J, Thompson AS, Thomson E, Thurman-Keup R, Tipton P, Tiwari V, Tkaczyk S, Toback D, Tollefson K, Tonelli D, Tönnesmann M, Torre S, Torretta D, Trischuk W, Tseng J, Tsuchiya R, Tsuno S, Tsybychev D, Turini N, Turner M, Ukegawa F, Unverhau T, Uozumi S, Usynin D, Vacavant L, Vaiciulis T, Varganov A, Vataga E, Vejcik S 3rd, Velev G, Veramendi G, Vickey T, Vidal R, Vila I, Vilar R, Volobouev I, von der Mey M, Wagner RG, Wagner RL, Wagner W, Wallace N, Walter T, Wan Z, Wang MJ, Wang SM, Warburton A, Ward B, Waschke S, Waters D, Watts T, Weber M, Wester W, Whitehouse B, Wicklund AB, Wicklund E, Williams HH, Wilson P, Winer BL, Wittich P, Wolbers S, Wolter M, Worcester M, Worm S, Wright T, Wu X, Würthwein F, Wyatt A, Yagil A, Yamashita T, Yamamoto K, Yang UK, Yao W, Yeh GP, Yi K, Yoh J, Yoon P, Yorita K, Yoshida T, Yu I, Yu S, Yu Z, Yun JC, Zanello L, Zanetti A, Zaw I, Zetti F, Zhou J, Zsenei A, Zucchelli S. Observation of the narrow state X(3872)-->J/psipi+pi- in pp collisions at sqaure root of s=1.96 TeV. Phys Rev Lett. 2004 Aug 13;93(7):072001. Epub 2004 Aug 9. PubMed PMID: 15324226.

5: Jeschke M, Wels W, Dengler W, Imber R, Stöcklin E, Groner B. Targeted inhibition of tumor-cell growth by recombinant heregulin-toxin fusion proteins. Int J Cancer. 1995 Mar 3;60(5):730-9. PubMed PMID: 7860149.